Recombination newcastle disease LaSota weak virus vaccine for expressing poultry influenza virus H5 sub type HA protein

An avian influenza virus, attenuated vaccine technology, applied in the direction of virus, antiviral agent, virus antigen components, etc., can solve the problem of not achieving widespread application

Active Publication Date: 2006-11-29
HARBIN VETERINARY RES INST CHINESE ACADEMY OF AGRI SCI
View PDF0 Cites 14 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to the shortcomings and defects of the above-mentioned expression system, the live virus vector itself, and the cost of use, it has not been widely used in actual production.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombination newcastle disease LaSota weak virus vaccine for expressing poultry influenza virus H5 sub type HA protein
  • Recombination newcastle disease LaSota weak virus vaccine for expressing poultry influenza virus H5 sub type HA protein
  • Recombination newcastle disease LaSota weak virus vaccine for expressing poultry influenza virus H5 sub type HA protein

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] Example 1 Construction of recombinant Newcastle disease LaSota attenuated vaccine strain expressing wild-type or mutant avian influenza virus H5 subtype hemagglutinin (HA) protein

[0043] Cells, viruses and test materials

[0044] BHK-21 cells (milk hamster kidney cells ATCC CCL-10), culture medium is DMEM (Dulbecco's modified Eagle's medium) containing 10% fetal bovine serum (Hyclone) and 1 μg / ml G418; NDV Lasota vaccine Strain AV1615 (purchased from China Center for Veterinary Culture Collection (CVCC)). The allantoic cavity of 9-10-day-old SPF chicken embryos was inoculated and frozen at -70°C for later use; chicken anti-NDV hyperimmune serum was prepared by our laboratory (Chu, H.P., G.Snell, D.J.Alexander, and G.C.Schild.1982 .Avian Pathol 11:227-234); SPF chicken embryos and SPF chicks were provided by the SPF Experimental Animal Center of Harbin Veterinary Research Institute. H5 subtype highly pathogenic avian influenza virus (HPAIV) A / Bar-headed goose / Qinghai...

Embodiment 2

[0054] Embodiment 2 Recombinant NDV expresses AVI HA protein indirect immunofluorescence assay (IFA) test

[0055] The NDV LaSota vaccine strain can transiently infect mammalian cells cultured in vitro. In order to prove the replication of rL-QHwH5 and rL-QHmH5 viruses in BHK-21 cells and the expression of virus antigens, the two allantoic viruses infected about 70-80% of monolayer BHK-21 cells with MOI as 1 respectively ( image 3 A and B), while using the NDV wild-type LaSota vaccine strain infected cells as a control ( image 3 C), 20 hours after the infection, the early CPE (cytopathic) phenomenon appeared in the cells, and immediately carried out indirect immunofluorescence staining with the positive serum of NDV high-immune SPF chickens as the detection antibody. As a result, strong positive reactions were observed under the fluorescence microscope of three kinds of virus-infected cells ( image 3 A, B and C) More specifically, the experimental steps are as follows:

...

Embodiment 3

[0058] Growth characteristics and pathogenicity characteristics of embodiment 3 rNDV in chicken embryo

[0059] In order to determine the growth characteristics of rL-QHwH5 and rL-QHmH5 chicken embryos rescued by reverse genetic manipulation and their pathogenicity to chicken embryos, the rescued virus chicken embryos were amplified in the F1 generation by 1×10 4 EID50 Inoculate the allantoic cavity of 9-10-day-old SPF chicken embryos. The wild-type Newcastle disease virus LaSota vaccine strain (rLaSota that reverse genetic operation rescued of result uses transcription vector pBTRT and transcription auxiliary plasmid pBSNP, pBSP and pBSL promptly, the wild-type virus rescued by reverse genetic operation as described in the present invention Newcastle disease virus LaSota vaccine strain AV161) completely non-lethal SPF chicken embryos within 120 hours, allantoic fluid was harvested 24 hours, 48 ​​hours, 72 hours and 96 hours after inoculation, EID per milliliter of allantoic f...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to reconstructing LaSota weak poison vaccine strain to express wild type or mutant type fowl influenza virus H5 HA albumen. Concretely, it is rL-QHwH5 and rL-QHmH5. The invention also discloses the method to make the LaSota weak poison vaccine and the application in defending fowl influenza virus.

Description

technical field [0001] The present invention relates to the field of recombinant virus vaccines, more specifically, the present invention relates to a recombinant Newcastle disease LaSota attenuated vaccine strain expressing a gene encoding wild-type or mutant avian influenza virus H5 subtype hemagglutinin (HA) protein, more specifically The recombinant Newcastle disease LaSota attenuated vaccine strains are rL-QHwH5 and rL-QHmH5. The invention also discloses a method for preparing the recombinant Newcastle disease LaSota attenuated vaccine strain and the application of the recombinant Newcastle disease LaSota attenuated vaccine strain in preparing vaccines for preventing bird flu. Background technique [0002] Newcastle disease virus (NDV) is a non-segmented single-stranded negative-sense RNA virus. As an important member and model virus of the Paramyxoviridae family, it has been deeply studied. Recombinant NDV has extraordinary advantages as a live virus vaccine carrier: ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/33C12N15/45C12N7/01A61K39/17C12N15/63
CPCC12N2760/18143A61K2039/5256A61K39/145C12N2760/16134C12N15/86A61K39/12A61P31/14
Inventor 步志高陈化兰
Owner HARBIN VETERINARY RES INST CHINESE ACADEMY OF AGRI SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap